Potential Prognostic Role of Immune System Activation Marker Neopterin in Patients With Type 2 Diabetes

Journal of Medical Biochemistry - Serbia
doi 10.2478/jomb-2018-0004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Related search

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context
Molecular MedicinePharmacology
2019English

Glucokinase and the Potential of Glucokinase Activation in Type 2 Diabetes

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Letter to the Editor About PNPLA3 Gene Polymorphism in Brazilian Patients With Type 2 Diabetes: A Prognostic Marker Beyond Liver Disease?

Nutrition, Metabolism and Cardiovascular Diseases
NutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMedicineMetabolismDiabetes
2020English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Role of IL-1β Modifications in Older Patients With Type 2 Diabetes

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Role of Vitamin B12 Deficiency in Patients With Type 2 Diabetes Mellitus

Journal of Medical Science And clinical Research
2018English

Serum Visfatin as a Novel Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes

International Journal of Contemporary Medical Research [IJCMR]
2018English

Prognostic Value of Admission Heart Rate in Patients With ST-segment Elevation Myocardial Infarction: Role of Type 2 Diabetes Mellitus

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy